Levomilnacipran
Back to searchMolecule Structure
Scientific Name
Levomilnacipran
Description of the Drug
Levomilnacipran is a selective serotonin and norepinephrine reuptake inhibitor (SNRI) used to treat major depressive disorder (MDD).
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB08918
http://www.drugbank.ca/drugs/DB08918
Brand Name(s)
Fetzima
Company Owner(s)
Amneal Pharmaceuticals Co Gmbh, Allergan Sales Llc, Hikma Pharmaceuticals Usa Inc
Mechanism(s) Of Action
Target Name | Target Type | Action Type | Target ChEMBL ID |
---|---|---|---|
Serotonin transporter | SINGLE PROTEIN | INHIBITOR | CHEMBL228 |
Norepinephrine transporter | SINGLE PROTEIN | INHIBITOR | CHEMBL222 |
Clinical Trial(s)
Unichem Links
SureChEMBL | SCHEMBL1414867 | ||
DrugBank | DB08918 | ||
PubChem: Thomson Pharma | 16010452 | ||
PubChem | 6917779 | ||
Nikkaji | J259.860D | ||
BindingDB | 50032379 | ||
DrugCentral | 4864 | ||
ChemicalBook | CB13133687 | ||
Guide to Pharmacology | 7435 | ||
rxnorm | LEVOMILNACIPRAN | LEVOMILNACIPRAN HYDROCHLORIDE | FETZIMA |
ChEBI | 136040 | ||
ZINC | ZINC000000000506 |